Novel small-molecule therapy of Hodgkin lymphoma

被引：8
|
作者：
Buglio, D. [1 ]
Georgakis, G. [1 ]
Younes, A. [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX 77030 USA
来源：
EXPERT REVIEW OF ANTICANCER THERAPY | 2007年 / 7卷 / 05期
关键词：
Bcl-2; bortezomib; HDAC; HSP90; mTOR; Reed-Sternberg;
D O I：
10.1586/14737140.7.5.735
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The treatment of Hodgkin lymphoma continues to be based on combination chemotherapy and radiation therapy. Although this treatment strategy produces a high cure rate, short- and long-term toxic effects continue to be problematic for young cured patients. In this review we focus on emerging novel therapies using small molecules that target specific survival pathways in the cancer cells. This approach is aimed at improving the cure rate while reducing treatment-related toxicity.
引用
收藏
页码：735 / 740
页数：6
相关论文
共 50 条
  • [1] Small-molecule PROTACs: novel agents for cancer therapy
    Wan, Yichao
    Yan, Chunxing
    Gao, Han
    Liu, Tingting
    [J]. FUTURE MEDICINAL CHEMISTRY, 2020, 12 (10) : 915 - 938
  • [2] Development of anaplastic lymphoma kinase (ALK) small-molecule inhibitors for cancer therapy
    Li, Rongshi
    Morris, Stephan W.
    [J]. MEDICINAL RESEARCH REVIEWS, 2008, 28 (03) : 372 - 412
  • [3] Novel therapy for Hodgkin lymphoma
    Batlevi, Connie Lee
    Younes, Anas
    [J]. HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2013, : 394 - 399
  • [4] Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapy
    Webb, Thomas R.
    Slavish, Jake
    George, Rani E.
    Look, A. Thomas
    Xue, Liquan
    Jiang, Qin
    Cui, Xiaoli
    Rentrop, Walter B.
    Morris, Stephan W.
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (03) : 331 - 356
  • [5] Novel small molecule CRM-1 inhibitor for Non Hodgkin's Lymphoma
    Azmi, Asfar S.
    Shacham, Sharon
    McCauley, Dilara
    Kauffman, Michael
    Mohammad, Ramzi M.
    [J]. CANCER RESEARCH, 2012, 72
  • [6] Novel small-molecule CRM-1 inhibitor for GI cancer therapy
    Azmi, Asfar S.
    Kauffman, Michael
    McCauley, Dilara
    Shacham, Sharon
    Mohammad, Ramzi M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [7] Small-molecule bromodomain inhibitors for cancer therapy
    Qi, Jun
    Filippakopoulos, Panagis
    Picaud, Sarah
    Smith, William
    Keates, Tracy
    Morse, Elizabeth
    Philpott, Martin
    Shaw, Katharin
    Fedorov, Oleg
    West, Nathan
    Heightman, Tom
    French, Christopher
    Knapp, Stefan
    Bradner, James
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
  • [8] Small-molecule Bax agonists for cancer therapy
    Meiguo Xin
    Rui Li
    Maohua Xie
    Dongkyoo Park
    Taofeek K. Owonikoko
    Gabriel L. Sica
    Patrick E. Corsino
    Jia Zhou
    Chunyong Ding
    Mark A. White
    Andrew T. Magis
    Suresh S. Ramalingam
    Walter J. Curran
    Fadlo R. Khuri
    Xingming Deng
    [J]. Nature Communications, 5
  • [9] Small-molecule delivery by nanoparticles for anticancer therapy
    Chen, Zhuo
    [J]. TRENDS IN MOLECULAR MEDICINE, 2010, 16 (12) : 594 - 602
  • [10] Small-molecule Bax agonists for cancer therapy
    Xin, Meiguo
    Li, Rui
    Xie, Maohua
    Park, Dongkyoo
    Owonikoko, Taofeek K.
    Sica, Gabriel L.
    Corsino, Patrick E.
    Zhou, Jia
    Ding, Chunyong
    White, Mark A.
    Magis, Andrew T.
    Ramalingam, Suresh S.
    Curran, Walter J.
    Khuri, Fadlo R.
    Deng, Xingming
    [J]. NATURE COMMUNICATIONS, 2014, 5
12345